期刊文献+

干扰素-γ基因转导前后人肝癌细胞HepG1表型变化及基因表达图谱差异的研究 被引量:4

Study on the Difference of Genotype and Gene Expression Profile of Human Hepatocellular Carcinoma Cell HepG1 Transduced with Interferon-r Gene
下载PDF
导出
摘要 目的:比较人肝癌细胞经干扰素(IFN)-γ基因转导前后细胞表型及基因表达图谱的差异。方法:①用扫描电镜、流式细胞仪等方法观察IFN-γ基因转导前后人肝癌细胞HepG1表型的变化;③应用微阵列膜片分别与未转导及转导了IFN-γ基因的HepG1 mRNA进行杂交,同时设一转导空白载体LXSN的HepG1 mRNA与膜片杂交作为对照,比较杂交信号,获得表达差异的基因。结果:①IFN-γ基因转导的HepG1细胞生长速度减慢,表面绒毛结构数量增多,绒毛变细、变长,HLAⅠ类和Ⅱ类分子表达增高;②IFN-γ基因转导后,HepG1细胞有多种基因的表达发生变化,其中一些基因较未转导IFN-γ时表达增高,一些较未转导IFN-γ时表达减低。表达发生变化的基因主要为与细胞周期和细胞凋亡相关的基因。结论:IFN-γ基因修饰HepG1细胞后使细胞表型发生变化,并且在基因表达上也发生改变。运用微阵列技术为进一步了解这些基因的相互关系及其与肿瘤生物学行为的关系奠定了基础,也可为优化肿瘤免疫基因治疗提供线索。 Background/Aims: To compare the difference of phenotype and gene expression profile of human hepatocellular carcinoma cells transduced or not with interferon (IFN)-γ gene. Methods: 1. Using scanning microscope and FACS to detect the change of phenotype of HepG1 transduced with IFN-γ gene; 2. Using microarray membranes to hybridize with HepG1, HepG1-IFN-γ, and HepG1-LXSN mRNA, respectively, then compared their hybridized signal and the difference of their gene expression. Results: 1. The growth speed of HepG1-IFN-γ decreased, the amount of surface microvilli increased and surface microvilli became thinner and elongated. the expression level of HLA I and II molecules also increased; 2. After transduced with IFN-γ gene, the expression level of many genes in HepG1 were changed, some decreased and others increased. The changed genes were mainly associated with cell cycle and apoptosis. Conclusions: HepG1 transduced with IFN-γ gene could produce changes of phenotype and gene expression. Using microarrays technology enables us to learn more information about the interrelationship among those changed genes and their association with tumorigenicity, it also provides us some clues to the advantageous tumor immuno-gene therapy strategy.
出处 《胃肠病学》 2001年第4期211-214,共4页 Chinese Journal of Gastroenterology
关键词 肝肿瘤 基因表达 基因转导 干扰素-γ基因 基因治疗 Liver Neoplasms Cells Gene Expression Transduction, Genetic
  • 相关文献

参考文献3

二级参考文献22

  • 1蒋小陵.细胞因子基因修饰前后人肝癌细胞基因表达变化分析.上海第二医科大学博士学位论文[M].,1999..
  • 2陈诗书,生物工程进展,1994年,14卷,30页
  • 3张腾飞,生物化学杂志
  • 4唐展云,中国生物化学与分子生物学报,1999年,15卷,48页
  • 5蒋小陵,博士学位论文,1999年
  • 6Qian Shubing,Chin Med J,1998年,111卷,319页
  • 7钱书兵,上海免疫学杂志,1998年,18卷,271页
  • 8许--,中国肿瘤生物治疗杂志,1998年,5卷,199页
  • 9钱书兵,中华微生物学和免疫学杂志,1998年,18卷,505页
  • 10徐荣婷,上海第二医科大学学报,1997年,17卷,182页

共引文献11

同被引文献99

  • 1卢绮萍,曹廷加.人肝热缺血安全时限的基因芯片分析[J].中华肝胆外科杂志,2004,10(6):366-368. 被引量:3
  • 2吴海东,汤华,王晶,刘民,李欣.喉癌发生相关特异基因筛选与验证[J].中国生物化学与分子生物学报,2007,23(3):245-248. 被引量:3
  • 3J萨姆布鲁克,DW拉塞尔.黄培堂等译.分子克隆实验指南[M].3版,北京:科学出版社,2002:1256-1257;1713-1720.
  • 4Ma X, Zhao H, Shan J, et al. PDCD10 interacts with Ste20- related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway[J]. Mol Biol Cell, 2007, 18(6) : 1965-1978.
  • 5Bergametti F, Denier C, Labauge P, et al. Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations[J]. Am J Hum Genet, 2005, 76(1) :42-51.
  • 6Hilder T L, Malone M H, Bencharit S, et al. Proteomic identification of the cerebral cavernous malformation signaling complex[J]. J Proteome Res, 2007, 6(11) :4343-4355.
  • 7Tanriover G, Boylan A J, Diluan M L, et al. PDCD10, the gene mutated in cerebral cavernous malformation 3, is expressed in the neurovascular unit[J]. Neurosurgery, 2008, 62 (4) : 930-938.
  • 8Nanjundan M, Nakayama Y, Cheng K W, et al. Amplification of MDS1/EVI1 and EVIl, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer [J]. Cancer Res, 2007, 67(7):3074-3084.
  • 9Aguirre A J, Brennan C, Bailey G, et al. High-resolution characterization of the pancreatic adenocarcinoma genome [ J ]. Proc Natl Acad Sci USA, 2034, 101(24) :9067-9072.
  • 10Cardoso J, Boer J, Morreau H, et al. Expression and genomic profiling of colorectal cancer [ J ]. Biochim Biophys Acta, 2007, 1775( 1 ) : 103-137.

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部